Raymond James & Associates’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $498K | Buy |
17,598
+249
| +1% | +$7.04K | ﹤0.01% | 3103 |
|
2024
Q2 | $332K | Sell |
17,349
-4,845
| -22% | -$92.6K | ﹤0.01% | 3292 |
|
2024
Q1 | $728K | Sell |
22,194
-1,161
| -5% | -$38.1K | ﹤0.01% | 2794 |
|
2023
Q4 | $771K | Sell |
23,355
-5,138
| -18% | -$170K | ﹤0.01% | 2672 |
|
2023
Q3 | $776K | Sell |
28,493
-15,986
| -36% | -$435K | ﹤0.01% | 2603 |
|
2023
Q2 | $1.35M | Buy |
44,479
+167
| +0.4% | +$5.06K | ﹤0.01% | 2298 |
|
2023
Q1 | $1.44M | Sell |
44,312
-2,968
| -6% | -$96.3K | ﹤0.01% | 2221 |
|
2022
Q4 | $1.33M | Sell |
47,280
-60,479
| -56% | -$1.7M | ﹤0.01% | 2265 |
|
2022
Q3 | $3.87M | Buy |
107,759
+42,018
| +64% | +$1.51M | ﹤0.01% | 1552 |
|
2022
Q2 | $2.02M | Sell |
65,741
-736
| -1% | -$22.6K | ﹤0.01% | 1971 |
|
2022
Q1 | $2.15M | Sell |
66,477
-20,511
| -24% | -$662K | ﹤0.01% | 2079 |
|
2021
Q4 | $2.41M | Buy |
86,988
+10,446
| +14% | +$289K | ﹤0.01% | 2041 |
|
2021
Q3 | $2.37M | Sell |
76,542
-1,966
| -3% | -$61K | ﹤0.01% | 1980 |
|
2021
Q2 | $1.66M | Buy |
78,508
+22,893
| +41% | +$483K | ﹤0.01% | 2229 |
|
2021
Q1 | $1.12M | Buy |
55,615
+2,910
| +6% | +$58.8K | ﹤0.01% | 2426 |
|
2020
Q4 | $845K | Buy |
52,705
+9,845
| +23% | +$158K | ﹤0.01% | 2440 |
|
2020
Q3 | $532K | Sell |
42,860
-954
| -2% | -$11.8K | ﹤0.01% | 2564 |
|
2020
Q2 | $312K | Buy |
43,814
+34
| +0.1% | +$242 | ﹤0.01% | 2878 |
|
2020
Q1 | $238K | Buy |
43,780
+2,485
| +6% | +$13.5K | ﹤0.01% | 2906 |
|
2019
Q4 | $374K | Sell |
41,295
-6,803
| -14% | -$61.6K | ﹤0.01% | 2928 |
|
2019
Q3 | $346K | Buy |
48,098
+23,542
| +96% | +$169K | ﹤0.01% | 2904 |
|
2019
Q2 | $195K | Sell |
24,556
-6,447
| -21% | -$51.2K | ﹤0.01% | 3248 |
|
2019
Q1 | $390K | Buy |
31,003
+3,202
| +12% | +$40.3K | ﹤0.01% | 2819 |
|
2018
Q4 | $555K | Buy |
27,801
+11,907
| +75% | +$238K | ﹤0.01% | 2480 |
|
2018
Q3 | $451K | Sell |
15,894
-536
| -3% | -$15.2K | ﹤0.01% | 2770 |
|
2018
Q2 | $346K | Buy |
16,430
+257
| +2% | +$5.41K | ﹤0.01% | 2916 |
|
2018
Q1 | $230K | Buy |
16,173
+1,574
| +11% | +$22.4K | ﹤0.01% | 3043 |
|
2017
Q4 | $180K | Buy |
14,599
+17
| +0.1% | +$210 | ﹤0.01% | 3068 |
|
2017
Q3 | $260K | Sell |
14,582
-26
| -0.2% | -$464 | ﹤0.01% | 2857 |
|
2017
Q2 | $370K | Buy |
+14,608
| New | +$370K | ﹤0.01% | 2579 |
|